Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00609193 · ClinicalTrials.gov registry record
Functional and Neurochemical Brain Changes in First-episode Bipolar Mania
A clinical trial, sponsored by University of Cincinnati.
- Completed
- Registry status
- 81
- Enrollment target
NCT00609193 is a clinical trial that has completed, run by University of Cincinnati. The registered enrollment target is 81 participants.
The verdict
NCT00609193 has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
Study Summary
The purpose of this study is to use magnetic resonance imaging (MRI) to examine brain structure, function and chemistry in people with bipolar disorder who are being treated with either quetiapine or lithium. Both of these medicines are FDA-approved to treat mania in adults and lithium is also FDA approved in children; quetiapine is commonly used in children with mania, but is not FDA approved for this indication in this age group.
Interventions
- DRUG quetiapine
- DRUG lithium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2008-01 |
| Est. Completion | 2015-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00609193
The ClinicalTrials.gov registry entry for NCT00609193 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which quetiapine is the first listed.
NCT00609193 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00609193 about?
NCT00609193 is a clinical study titled "Functional and Neurochemical Brain Changes in First-episode Bipolar Mania". The purpose of this study is to use magnetic resonance imaging (MRI) to examine brain structure, function and chemistry in people with bipolar disorder who are being treated with either quetiapine or lithium. Both of these medicines are FDA-approved to treat mania in adults and lithium is also FDA a...
What is the current status of trial NCT00609193?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2008-01. Estimated completion is 2015-07.
What interventions are being tested in trial NCT00609193?
The interventions under investigation include: quetiapine (DRUG), lithium (DRUG).
Who is sponsoring clinical trial NCT00609193?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.